US 9629897
Methods of producing and using regulatory B-cells
granted A61KA61K38/162A61K38/20
Quick answer
US patent 9629897 (Methods of producing and using regulatory B-cells) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K38/162, A61K38/20, A61K38/208, A61K40/13